✦ LIBER ✦

Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

✍ Scribed by Joëlle Micallef; Shahram Attarian; Odile Dubourg; Pierre-Marie Gonnaud; Jean-Yves Hogrel; Tanya Stojkovic; Rafaelle Bernard; Elisabeth Jouve; Severine Pitel; Francois Vacherot; Jean-Francois Remec; Laurent Jomir; Eric Azabou; Mahmoud Al-Moussawi; Marie-Noelle Lefebvre; Laurence Attolini; Sadek Yaici; Daniel Tanesse; Michel Fontes; Jean Pouget; Olivier Blin

Book ID: 114409335
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 169 KB
Volume: 8
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(09)70260-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ascorbic acid for Charcot–Marie–Tooth di

Ascorbic acid for Charcot–Marie–Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial

✍ Joshua Burns; Robert A Ouvrier; Eppie M Yiu; Pathma D Joseph; Andrew J Kornberg; 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 179 KB

Ascorbic acid in Charcot–Marie–Tooth dis

Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

✍ Davide Pareyson; Mary M Reilly; Angelo Schenone; Gian Maria Fabrizi; Tiziana Cav 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 212 KB

A multicenter, randomized, double-blind,

A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): The study protocol [EudraCT no.: 2006-000032-27]

✍ Davide Pareyson; Angelo Schenone; Gian Maria Fabrizi; Lucio Santoro; Luca Padua; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Effects of antiretroviral therapy in pat

Effects of antiretroviral therapy in patients with Charcot-Marie-Tooth disease type 1A

✍ J. L. Fernández-Torre; M. García-Alcalde; V. Alvarez 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 120 KB

Effect of flumazenil on the electroencep

Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial

✍ Michael Groeneweg; Klaus Gyr; Roman Amrein; Giuseppe Scollo-Lavizzari; Roger Wil 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 497 KB

Co-stimulation modulation with abatacept

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

✍ Tihamer Orban; Brian Bundy; Dorothy J Becker; Linda A DiMeglio; Stephen E Gitelm 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 393 KB